Taho Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2017	FY 2016	2015 - 2011
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	2015 - 2011
Market Capitalization	6,398	2,274	-	-	616	549	Upgrade
Market Cap Growth	77.45%	-	-	-	12.10%	-59.61%	Upgrade
Enterprise Value	6,011	2,074	-	-	430	279	Upgrade
Last Close Price	124.50	44.35	-	-	11.76	10.49	Upgrade
PS Ratio	822.49	-	-	-	49.65	15.25	Upgrade
PB Ratio	14.35	4.41	-	-	3.55	1.76	Upgrade
P/TBV Ratio	14.38	4.41	-	-	3.94	1.89	Upgrade
EV/Sales Ratio	-	-	-	-	34.70	7.75	Upgrade
Debt / Equity Ratio	0.03	0.03	0.11	-	0.01	0.00	Upgrade
Net Debt / Equity Ratio	-0.87	-0.93	-1.01	-1.15	-0.74	-0.72	Upgrade
Net Debt / EBITDA Ratio	2.30	2.85	1.76	1.84	1.40	2.41	Upgrade
Net Debt / FCF Ratio	2.25	2.89	1.94	1.67	0.92	2.17	Upgrade
Asset Turnover	0.02	-	0.01	-	0.05	0.09	Upgrade
Inventory Turnover	-	-	-	-	2.18	2.02	Upgrade
Quick Ratio	35.53	15.02	3.85	2.29	5.13	19.17	Upgrade
Current Ratio	35.74	15.09	3.91	2.39	5.70	20.53	Upgrade
Return on Equity (ROE)	-48.14%	-46.32%	-80.79%	-	-56.44%	-29.72%	Upgrade
Return on Assets (ROA)	-29.12%	-25.20%	-35.89%	-	-25.53%	-17.73%	Upgrade
Return on Capital Employed (ROCE)	-37.70%	-32.20%	-54.20%	-72.50%	-61.60%	-34.70%	Upgrade
Earnings Yield	-2.59%	-7.36%	-	-	-22.27%	-19.88%	Upgrade
FCF Yield	-2.69%	-7.29%	-	-	-22.48%	-18.79%	Upgrade
Buyback Yield / Dilution	-17.82%	-17.18%	-7.73%	31.26%	-	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.